Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin may treat rosacea and Alzheimer's by reducing inflammation and affecting blood vessel growth.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Topical eflornithine helps maintain hair reduction after IPL therapy in women with facial hirsutism.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Finasteride can cause melasma, especially in people with darker skin.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Pregnancy can trigger severe rosacea, which may be treated with antibiotics and steroids, but there's no clear treatment guideline.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Ruxolitinib cream may help treat severe hair loss in children.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Lupus severely affects daily life, work, and mental health, with many experiencing frequent flares and medication side-effects.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.